Kerem Karaman1, Kaan Mansıroglu2, Ozkan Subasi2, Aytac Biricik2, Hakan Yirgin2, Elif Kose3, Metin Ercan2. 1. Department of Gastroenterological Surgery, Sakarya University Teaching and Research Hospital, Adnan Menderes Cad. Sağlık Sok No:195, Genel Cerrahi Klinigi, 54100, Adapazarı, Sakarya, Turkey. karaman_kerem@yahoo.com.tr. 2. Department of Gastroenterological Surgery, Sakarya University Teaching and Research Hospital, Adnan Menderes Cad. Sağlık Sok No:195, Genel Cerrahi Klinigi, 54100, Adapazarı, Sakarya, Turkey. 3. Department of Public Health, Sakarya University Teaching and Research Hospital, Adapazarı, Sakarya, Turkey.
Abstract
BACKGROUND: The effect of bariatric surgery on thyroid hormone changes yielded inconsistent results. The aim of the present study was to assess the change of thyroid hormone levels following laparoscopic sleeve gastrectomy (LSG), with or without antral preservation (AP). METHODS: Thyroid hormones (TSH, FT3, FT4) were examined preoperatively, at the end of the first postoperative month, and first postoperative year. Secondly, antral resection (AR) and AP were compared at inducing weight loss and thereby affecting thyroid hormone levels. RESULTS: Euthyroid obese patients (86 female/20 male) underwent LSG. Of these, 58 patients underwent AR and 48 patients AP. The mean FT3 levels significantly decreased both in the first postoperative month and the first year (P < 0.001), whereas mean TSH levels decreased significantly in the first postoperative year (P < 0.001). FT4 levels remained nearly unchanged (P = 0.517). Postoperative first year body mass index (BMI) loss, excess BMI loss percentile (%EBMIL), and total body weight loss percentile (%TWL) were significantly higher in AR group than the AP group (P ≤ 0.01). When the change in thyroid hormone levels was analyzed by pyloric distance according to time periods, no significant difference was found in TSH and FT4 levels (P > 0.05); however, reduction in FT3 levels was significantly greater in patients with AR than in AP patients (P = 0.028). CONCLUSION: LSG promotes significant reduction in TSH and FT3 levels, whereas FT4 levels remain unchanged. LSG with AR provides more weight loss in short term and appears to be more effective at lowering FT3 levels.
BACKGROUND: The effect of bariatric surgery on thyroid hormone changes yielded inconsistent results. The aim of the present study was to assess the change of thyroid hormone levels following laparoscopic sleeve gastrectomy (LSG), with or without antral preservation (AP). METHODS: Thyroid hormones (TSH, FT3, FT4) were examined preoperatively, at the end of the first postoperative month, and first postoperative year. Secondly, antral resection (AR) and AP were compared at inducing weight loss and thereby affecting thyroid hormone levels. RESULTS: Euthyroid obesepatients (86 female/20 male) underwent LSG. Of these, 58 patients underwent AR and 48 patients AP. The mean FT3 levels significantly decreased both in the first postoperative month and the first year (P < 0.001), whereas mean TSH levels decreased significantly in the first postoperative year (P < 0.001). FT4 levels remained nearly unchanged (P = 0.517). Postoperative first year body mass index (BMI) loss, excess BMI loss percentile (%EBMIL), and total body weight loss percentile (%TWL) were significantly higher in AR group than the AP group (P ≤ 0.01). When the change in thyroid hormone levels was analyzed by pyloric distance according to time periods, no significant difference was found in TSH and FT4 levels (P > 0.05); however, reduction in FT3 levels was significantly greater in patients with AR than in AP patients (P = 0.028). CONCLUSION: LSG promotes significant reduction in TSH and FT3 levels, whereas FT4 levels remain unchanged. LSG with AR provides more weight loss in short term and appears to be more effective at lowering FT3 levels.
Authors: C S Mantzoros; M Ozata; A B Negrao; M A Suchard; M Ziotopoulou; S Caglayan; R M Elashoff; R J Cogswell; P Negro; V Liberty; M L Wong; J Veldhuis; I C Ozdemir; P W Gold; J S Flier; J Licinio Journal: J Clin Endocrinol Metab Date: 2001-07 Impact factor: 5.958
Authors: Draženka Janković; Peter Wolf; Christian-Heinz Anderwald; Yvonne Winhofer; Miriam Promintzer-Schifferl; Astrid Hofer; Felix Langer; Gerhard Prager; Bernhard Ludvik; Alois Gessl; Anton Luger; Michael Krebs Journal: Obes Surg Date: 2012-01 Impact factor: 4.129
Authors: Ignace M C Janssen; Jens Homan; Wendy Schijns; Bark Betzel; Edo O Aarts; Frits J Berends; Hans de Boer Journal: Surg Obes Relat Dis Date: 2015-03-03 Impact factor: 4.734
Authors: Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou Journal: Thyroid Date: 2006-01 Impact factor: 6.568
Authors: L T van Hulsteijn; R Pasquali; F Casanueva; M Haluzik; S Ledoux; M P Monteiro; J Salvador; F Santini; H Toplak; O M Dekkers Journal: Eur J Endocrinol Date: 2020-01 Impact factor: 6.664